Is incoming government's drug policy good signal to pharmaceutical industry? (second part)

The next government will unlikely promote a friendlier business environment over the current drug pricing policy, as president-elect Lee Myung-bak vowed to slash the government' expenditure by 10 percent.

If this is the case, a number of existing medicines will be excluded from the health-insurance eligible category, and further price cutback of medicines will follow after re-evaluating the ...